drugset / Press release
rhNRG-1 and rhErbB3-f were Selected to “Shanghai Sci & Tech Prosperity Program” and “Huiyan Program”
2006-01-05 · Zensun Sci. & Tech. Co., Ltd. · original zensun.com ↗
In December 2005, Zensun’s two proprietary research projects - recombinant human Neuregulin-1 and recombinant human ErbB3 fragment (rhErbB3-f) immunization, were officially selected “Shanghai Sci & Tech Prosperity Program” and “Huiyan Program”
The release as fetched from its publisher. zensun.com ↗